Package Leaflet: Information for the User
Alprazolam Krka 2 mg tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Alprazolam Krka contains the active substance alprazolam. It belongs to a group of medicines called benzodiazepines (anxiolytic medicines).
Alprazolam Krka is used in adults for the treatment of anxiety symptoms that are severe, disabling or causing the patient great distress. This medicine is for short-term use only.
Do not take Alprazolam Krka:
Warnings and precautions
Talk to your doctor or pharmacist before taking Alprazolam Krka if you:
Dependence
Taking Alprazolam Krka can lead to physical and mental dependence. If you notice that you are having difficulty stopping taking this medicine, you may be mentally dependent on it. Physical dependence means that withdrawal symptoms occur when treatment with this medicine is stopped suddenly. The risk of dependence increases with dose and duration of treatment. To reduce the risks, the lowest possible dose should be used and the duration of treatment should be as short as possible. Follow your doctor's dosage recommendations. The risk is also greater in patients who abuse or have abused alcohol and drugs (see also section 3 “If you stop taking Alprazolam Krka”
Abuse
Drug abuse is a known risk when taking this medicine (see also section 4 “Possible side effects”). Abuse of this medicine can lead to overdose and death. Always follow your doctor's dosage recommendations. This medicine may be desirable to people who abuse prescription medicines and should be kept out of the reach of other people.
Effects on memory
During treatment with Alprazolam Krka, your memory may be affected. This usually occurs several hours after taking this medicine. Please ask your doctor if you notice this symptom.
Effects on mood
Treatment with Alprazolam Krka may increase the risk of hypomania or mania in patients with depression. Consult your doctor immediately if you notice symptoms of mania or hypomania.
Treatment with Alprazolam Krka may increase the risk of developing thoughts of self-harm or suicide if you suffer from depression. Consult your doctor before starting treatment with Alprazolam Krka.
If treatment with Alprazolam Krka is necessary and you are depressed or have had previous thoughts of suicide or self-harm, your doctor will monitor you closely. If you develop thoughts of self-harm or suicide at any time, contact your doctor or go to hospital immediately.
Children and adolescents
Alprazolam is not recommended for use in children and adolescents under 18 years.
Other medicines and Alprazolam Krka
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, especially the medicines listed below, as the effect of Alprazolam Krka or the other medicine may change when taken at the same time.
Taking Alprazolam Krka with food, drinks and alcohol
You can take the tablets with or without food. Swallow each tablet with a small amount of liquid.
It is important that you do not drink alcohol while taking Alprazolam Krka, as alcohol increases the adverse effects of this medicine.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Tell your doctor immediately if you are pregnant or plan to become pregnant. Observations in humans have indicated that alprazolam may be harmful to the foetus (increased risk of malformations, such as cleft palate). Do not take Alprazolam Krka if you are pregnant or plan to become pregnant, unless your doctor considers it essential. Your doctor will decide whether the possible benefits of treatment outweigh the risks to the foetus.
If you are taking Alprazolam Krka up to the time of delivery, inform your doctor, as your newborn baby may have some withdrawal symptoms when born.
Breast-feeding
Do not take Alprazolam Krka during breast-feeding, as this medicine may pass into breast milk.
Driving and using machines
Alprazolam Krka may cause side effects such as drowsiness, memory loss, muscle relaxation and decreased concentration. Therefore, your ability to react may be affected, especially if you have not slept enough. These effects may increase if you drink alcohol. Do not drive or use machines while taking Alprazolam Krka.
Alprazolam Krka contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
Your doctor will decide what dose of alprazolam is suitable for you, taking into account the symptoms of your illness and your tolerance. Preferably, treatment should be started, controlled and stopped by the same doctor. Treatment usually starts with a low dose, which is gradually increased if necessary according to your doctor's prescription. It takes 1 to 2 hours for the tablets to take effect. If you experience severe side effects after the first dose, your dose should be reduced. Do not change the dose without consulting your doctor first.
Treatment of anxiety
Recommended initial dose: take 0.25 – 0.5 mg three times a day.
Your doctor may increase the dose as needed. The recommended maintenance dose is 0.5 mg to 3 mg per day, divided into several doses.
Elderly patients and patients sensitive to the sedative effects of alprazolam
The initial dose is 0.25 mg two or three times a day in the treatment of anxiety disorder. Your doctor may increase the dose as needed.
Duration of treatment
The risk of dependence and abuse may increase with dose and duration of treatment. Your doctor will therefore prescribe the lowest effective dose for the shortest possible duration, and will frequently reassess the need to continue treatment (see section 2 “Warnings and precautions”).
The maximum duration of treatment should not exceed 2-4 weeks. Long-term treatment is not recommended. A decrease in effect may develop if used for more than a few weeks.
The score line is only to facilitate breaking the tablet if you have difficulty swallowing it whole.
Use in children and adolescents
The safety and efficacy of alprazolam in patients under 18 years have not been established. Therefore, the use of alprazolam is not recommended.
If you take more Alprazolam Krka than you should
If you take more tablets than your doctor prescribed (or if someone else takes your tablets), seek medical attention or go to the nearest hospital. Take the medicine pack with you.
Symptoms of an overdose may include:
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Alprazolam Krka
If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. Do not take a double dose to make up for a forgotten dose. Take your next dose as usual.
If you stop taking Alprazolam Krka
Always consult your doctor before stopping taking alprazolam, as the dose should be reduced gradually. If you stop treatment suddenly, withdrawal symptoms may occur, such as headache, muscle pain, severe anxiety, restlessness, confusion, irritability and sleep problems. In severe cases, the following symptoms may occur: altered perception of reality, depersonalization (a feeling in which you find yourself outside your own body), tingling and numbness of the arms and legs, intolerance to light, sounds and physical contact, hallucinations or epileptic fits (convulsions). These symptoms may occur for several days after stopping the tablets. When treatment with alprazolam is stopped, the symptoms that were initially the reason for treatment with this medicine may return and with greater intensity than before. In addition to the symptoms mentioned above, mood changes may also occur.
Therefore, your doctor will reduce the dose gradually when treatment is stopped. He/she will decide on the reduction of the dose individually, as the decrease in dose depends on several factors (e.g. duration of treatment and daily dose). If you are concerned, your doctor can give you more information about this.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience any of the following adverse effects, consult your doctor immediately, as your treatment should be discontinued:
Inform your doctor as soon as possible if you experience the following symptoms, as it may be necessary to change the dose or treatment:
Other possible side effects that may occur are:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Unknown: frequency cannot be estimated from available data
Previously undetected depression may become apparent in susceptible individuals.
Dependence and Withdrawal Symptoms
It is possible to become dependent on medicines like Alprazolam Krka while taking them, which increases the likelihood of having withdrawal symptoms when treatment is discontinued.
Withdrawal symptoms are more common if you:
This can cause effects such as headaches, muscle aches, extreme anxiety, tension, restlessness, confusion, mood changes, difficulty sleeping, and irritability. In severe cases of withdrawal, you may also experience the following symptoms: feeling unreal or indifferent, being unusually sensitive to sound, light, or physical contact, numbness and tingling in the feet and hands, hallucinations (seeing or hearing things that do not exist while awake), tremors, or epileptic seizures .Inform your doctor if withdrawal symptoms worsen or do not disappear.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Keep in the original packaging to protect it from moisture.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Alprazolam Krka 2 mg tablets.
Appearance of the Product and Package Contents
White to almost white, round, biconvex tablets, with beveled edges and scored on both sides. The tablet is marked on both sides with the engraving "2" on one side of the score, 9 mm in diameter. The score serves only to fractionate and facilitate swallowing but not to divide into equal doses.
Alprazolam Krka is available in packages of:
Only some package sizes may be marketed.
Marketing Authorization Holder
KRKA, d.d., Novo mesto Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturer
KRKA, d.d., Novo mesto Šmarješka cesta 6, 8501 Novo mesto, Slovenia
TAD Pharma GmbH
Heinz-Lohmann-Strabe 5
27472 Cuxhaven
Germany
This medicine is authorized in the Member States of the European Economic Area under the following names:
Member State Name | Medicine Name |
Hungary | Alprazolam Krka 2 mg tablets |
Bulgaria | ?????????? ???? 2 mg ???????? |
Cyprus | Alprazolam TAD 2 mg |
Denmark | Alprazolam Krka d.d. |
Estonia | Alprazolam Krka |
Spain | Alprazolam Krka 2 mg EFG tablets |
Portugal | Alprazolam TAD |
Sweden | Alprazolam Krka d.d. 2 mg tablets |
This prospectus has been approved in:March 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/